Director Rainer Gawlick filed a Form 4 with the SEC on November 4, 2026, disclosing a purchase of Proto Labs Inc common stock on November 3, 2026.

Key Highlights

  • Reporting person: Rainer Gawlick, identified as a Director of Proto Labs Inc (NYSE:PRLB).
  • Transaction: Purchase (transaction code P) of 720 shares of common stock on November 3, 2026.
  • Price paid: $68.18 per share, according to the filing.
  • Resulting ownership: Gawlick directly held 46,813 shares of common stock following the transaction.
  • No derivative activity: Table II of the filing reports no derivative securities acquired or disposed of.

Gawlick's November 2026 Open-Market Purchase of Proto Labs Common Stock

According to the Form 4 filed on November 4, 2026, Rainer Gawlick, a director of Proto Labs Inc, acquired 720 shares of Proto Labs common stock on November 3, 2026, at a price of $68.18 per share. The transaction was coded "P," indicating an open-market purchase. The filing was signed by W. Morgan Burns as Attorney-in-Fact for the reporting person.

Following the reported transaction, the filing states that Gawlick directly beneficially owned 46,813 shares of Proto Labs common stock. No indirect ownership or derivative securities positions were reported in connection with this filing. The form does not indicate that the transaction was made pursuant to a Rule 10b5-1 trading plan, as the corresponding checkbox was not marked.

What Was Disclosed

The filing disclosed a single open-market purchase by Director Rainer Gawlick of 720 shares of Proto Labs Inc (NYSE:PRLB) common stock at $68.18 per share on November 3, 2026, resulting in direct beneficial ownership of 46,813 shares.